|
Diabetes, Vol 46, Issue 10 1542-1547, Copyright © 1997 by American Diabetes Association
Involvement of beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) in the development of diabetes in obese diabetic mice
XD Yang, HK Sytwu, HO McDevitt and SA Michie
Department of Microbiology and Immunology, Stanford University School of Medicine, California, USA.
Nonobese diabetic (NOD) mice develop autoimmune-mediated lymphocytic
inflammation of pancreatic islets (insulitis) that leads to beta-cell
destruction and development of diabetes. Inflamed islets show expression of
lymphocyte alpha 4 beta 7 integrin and endothelial mucosal addressin cell
adhesion molecule-1 (MAdCAM-1), adhesion molecules involved in
tissue-selective migration of lymphocytes to mucosal lymphoid tissues. To
elucidate the roles of the mucosal lymphocyte/endothelial adhesion system
in the development of diabetes, we treated NOD mice with monoclonal
antibody against beta 7 integrin or MAdCAM-1. Treatment of mice from age 7
to 28 days or 8 to 12 weeks with either antibody led to significant and
long-standing protection against the spontaneous development of diabetes
and insulitis. In contrast, neither treatment prevented the development of
salivary gland inflammation (sialadenitis), indicating that the effect was
tissue-selective. Monoclonal antibody treatment had no demonstrable effect
on numbers or phenotypes of peripheral lymphocytes or on the immune
response to pancreatic islet or exogenous antigens. These data indicate
that lymphocyte and endothelial adhesion molecules involved in the
migration of lymphocytes into mucosal lymphoid tissues play a role in the
development of diabetes in NOD mice. Moreover, the results suggest that
treatment of humans with antibodies against tissue-selective lymphocyte or
endothelial adhesion molecules may selectively inhibit the development of
autoimmune diseases such as diabetes.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
O. Vaarala, M. A. Atkinson, and J. Neu
The "Perfect Storm" for Type 1 Diabetes: The Complex Interplay Between Intestinal Microbiota, Gut Permeability, and Mucosal Immunity
Diabetes,
October 1, 2008;
57(10):
2555 - 2562.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Hanninen, R. Nurmela, M. Maksimow, J. Heino, S. Jalkanen, and C. Kurts
Islet {beta}-Cell-Specific T Cells Can Use Different Homing Mechanisms to Infiltrate and Destroy Pancreatic Islets
Am. J. Pathol.,
January 1, 2007;
170(1):
240 - 250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Cantor and K. Haskins
Effector Function of Diabetogenic CD4 Th1 T Cell Clones: A Central Role for TNF-{alpha}
J. Immunol.,
December 1, 2005;
175(11):
7738 - 7745.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Graham, P Courtois, W J Malaisse, J Rozing, F W Scott, and A M. I Mowat
Enteropathy precedes type 1 diabetes in the BB rat
Gut,
October 1, 2004;
53(10):
1437 - 1444.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sasaki, J. W. Elrod, P. Jordan, M. Itoh, T. Joh, A. Minagar, and J. S. Alexander
CYP450 dietary inhibitors attenuate TNF-{alpha}-stimulated endothelial molecule expression and leukocyte adhesion
Am J Physiol Cell Physiol,
April 1, 2004;
286(4):
C931 - C939.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Westerholm-Ormio, O. Vaarala, P. Pihkala, J. Ilonen, and E. Savilahti
Immunologic Activity in the Small Intestinal Mucosa of Pediatric Patients With Type 1 Diabetes
Diabetes,
September 1, 2003;
52(9):
2287 - 2295.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Torrente, G. Camirand, F. Pisati, M. Belicchi, B. Rossi, F. Colombo, M. El Fahime, N. J. Caron, A. C. Issekutz, G. Constantin, et al.
Identification of a putative pathway for the muscle homing of stem cells in a muscular dystrophy model
J. Cell Biol.,
August 4, 2003;
162(3):
511 - 520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Friedline, C. P. Wong, D. A. Steeber, T. F. Tedder, and R. Tisch
L-Selectin Is Not Required for T Cell-Mediated Autoimmune Diabetes
J. Immunol.,
March 15, 2002;
168(6):
2659 - 2666.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kommajosyula, S. Reddy, K. Nitschke, J. R. Kanwar, M. Karanam, and G. W. Krissansen
Leukocytes infiltrating the pancreatic islets of nonobese diabetic mice are transformed into inactive exiles by combinational anti-cell adhesion therapy
J. Leukoc. Biol.,
October 1, 2001;
70(4):
510 - 517.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Oshima, K. P. Pavlick, F. S. Laroux, S. K. Verma, P. Jordan, M. B. Grisham, L. Williams, and J. S. Alexander
Regulation and distribution of MAdCAM-1 in endothelial cells in vitro
Am J Physiol Cell Physiol,
October 1, 2001;
281(4):
C1096 - C1105.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Mikulowska-Mennis, B. Xu, J. M. Berberian, and S. A. Michie
Lymphocyte Migration to Inflamed Lacrimal Glands Is Mediated by Vascular Cell Adhesion Molecule-1/{alpha}4{beta}1 Integrin, Peripheral Node Addressin/L-Selectin, and Lymphocyte Function-Associated Antigen-1 Adhesion Pathways
Am. J. Pathol.,
August 1, 2001;
159(2):
671 - 681.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. Ettinger, S. H. Munson, C.-C. Chao, M. Vadeboncoeur, J. Toma, and H. O. McDevitt
A Critical Role for Lymphotoxin-{beta} Receptor in the Development of Diabetes in Nonobese Diabetic Mice
J. Exp. Med.,
June 4, 2001;
193(11):
1333 - 1340.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Fan, C. R. Reilly, Y. Luo, M. E. Dorf, and D. Lo
Cutting Edge: Ectopic Expression of the Chemokine TCA4/SLC Is Sufficient to Trigger Lymphoid Neogenesis
J. Immunol.,
April 15, 2000;
164(8):
3955 - 3959.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Iizuka, T. Tanaka, M. Suematsu, S. Miura, T. Watanabe, R. Koike, Y. Ishimura, H. Ishii, N. Miyasaka, and M. Miyasaka
Stage-Specific Expression of Mucosal Addressin Cell Adhesion Molecule-1 During Embryogenesis in Rats
J. Immunol.,
March 1, 2000;
164(5):
2463 - 2471.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. G. Johnson, A. Mikulowska, E. C. Butcher, L. M. McEvoy, and S. A. Michie
Anti-CD43 Monoclonal Antibody L11 Blocks Migration of T Cells to Inflamed Pancreatic Islets and Prevents Development of Diabetes in Nonobese Diabetic Mice
J. Immunol.,
November 15, 1999;
163(10):
5678 - 5685.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Hoglund, J. Mintern, C. Waltzinger, W. Heath, C. Benoist, and D. Mathis
Initiation of Autoimmune Diabetes by Developmentally Regulated Presentation of Islet Cell Antigens in the Pancreatic Lymph Nodes
J. Exp. Med.,
January 18, 1999;
189(2):
331 - 339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Rietzler, M. Bittner, W. Kolanus, A. Schuster, and B. Holzmann
The Human WD Repeat Protein WAIT-1 Specifically Interacts with the Cytoplasmic Tails of beta 7-Integrins
J. Biol. Chem.,
October 16, 1998;
273(42):
27459 - 27466.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Enghofer, J. Bojunga, R. Ludwig, A. Oldenburg, A. Bernd, K. H. Usadel, and K. Kusterer
Lymphocyte transfer in streptozotocin-induced diabetes: adhesion of donor cells to islet endothelium
Am J Physiol Endocrinol Metab,
May 1, 1998;
274(5):
E928 - E935.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1997 by the American Diabetes Association.
|
|
| |
|